Trial
NCT03069950
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
The Cleveland Clinic; Oregon Health and Science University; Queens Cancer Center of Queens Hospital; Washington University School of Medicine
Condition
Colorectal Adenocarcinoma Metastatic to the Liver
Intervention
Floxuridine (FUDR)
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-21